Cargando…

Vascular Endothelium as a Target of Beraprost Sodium and Fenofibrate for Antiatherosclerotic Therapy in Type 2 Diabetes Mellitus

Diabetes mellitus is an important risk factor for cardiovascular morbidity and mortality. The metabolic abnormalities caused by diabetes mellitus induce vascular endothelial dysfunction that predisposes patients with diabetes mellitus to atherosclerosis. Two mega clinical trials showed that intensiv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Otsuki, Michio, Goya, Kayoko, Kasayama, Soji
Formato:	Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2005
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1993948/ https://www.ncbi.nlm.nih.gov/pubmed/17319106

Ejemplares similares

Effect of beraprost sodium on arterial stiffness in patients with type 2 diabetic nephropathy
por: Na, Ki Young, et al.
Publicado: (2013)

Effects of Beraprost Sodium on Subjective Symptoms in Diabetic Patients with Peripheral Arterial Disease
por: Yoon, Hang Seob, et al.
Publicado: (2013)

Ameliorative Effect of Beraprost Sodium on Celecoxib Induced Cardiotoxicity in Rats
por: Ahmad, Shafique, et al.
Publicado: (2018)

RAGE and TLRs as Key Targets for Antiatherosclerotic Therapy
por: Olejarz, Wioletta, et al.
Publicado: (2018)

Beraprost Sodium for Pulmonary Hypertension in Dogs: Effect on Hemodynamics and Cardiac Function
por: Suzuki, Ryohei, et al.
Publicado: (2022)

Beraprost sodium protects against chronic brain injury in aluminum-overload rats
por: Pan, Yongquan, et al.
Publicado: (2015)

Beneficial Effect of Beraprost Sodium Plus Aspirin in the Treatment of Acute Ischemic Stroke
por: Chen, Siqia, et al.
Publicado: (2017)

Beraprost Sodium Delays the Decline of Glomerular Filtration Rate in Patients with Diabetic Nephropathy: A Retrospective Study
por: Zhou, Jingjing, et al.
Publicado: (2023)

Two barriers for sodium in vascular endothelium?
por: Oberleithner, Hans
Publicado: (2012)

Glycocalyx–Sodium Interaction in Vascular Endothelium
por: Sembajwe, Lawrence Fred, et al.
Publicado: (2023)

Antiatherosclerotic Effects of Sodium-Glucose Cotransporter 2 Inhibitors: An Underrecognized Piece of the Big Puzzle?
por: Koufakis, Theocharis, et al.
Publicado: (2022)

Short-Term Effects of Beraprost Sodium on the Markers for Cardiovascular Risk Prediction in Type 2 Diabetic Patients with Microalbuminuria
por: Choi, Yun Mi, et al.
Publicado: (2019)

Correction to: Beraprost Sodium Delays the Decline of Glomerular Filtration Rate in Patients with Diabetic Nephropathy: A Retrospective Study
por: Zhou, Jingjing, et al.
Publicado: (2023)

Investigation of Beraprost Sodium on Cardiac Function and Hemodynamics in Canine Models of Chronic Pulmonary Hypertension
por: Suzuki, Ryohei, et al.
Publicado: (2022)

Clinical efficacy and safety of beraprost sodium in the treatment of nephrotic syndrome: A meta-analysis
por: Yan, Peng, et al.
Publicado: (2023)

Catalytic asymmetric formal synthesis of beraprost
por: Kobayashi, Yusuke, et al.
Publicado: (2015)

Correlation of glycated albumin but not hemoglobin A(1c) with endogenous insulin secretion in fulminant type 1 diabetes mellitus
por: Koga, Masafumi, et al.
Publicado: (2010)

Antiobesogenic and Antiatherosclerotic Properties of Caralluma fimbriata Extract
por: Kamalakkannan, Soundararajan, et al.
Publicado: (2010)

Cell-Based Models for Development of Antiatherosclerotic Therapies
por: Zakiev, Emile R., et al.
Publicado: (2017)

Prospective analysis of the efficacy of beraprost sodium combined with alprostadil on diabetic nephropathy and influence on rennin-angiotensin system and TNF-α
por: Xu, Xinwei, et al.
Publicado: (2020)

The Prostacyclin Analog Beraprost Sodium Ameliorates Characteristics of Metabolic Syndrome in Obese Zucker (Fatty) Rats
por: Sato, Nahoko, et al.
Publicado: (2010)

The effect of combination therapy of allicin and fenofibrate on high fat diet-induced vascular endothelium dysfunction and liver damage in rats
por: Li, Weihong, et al.
Publicado: (2010)

Glycated Albumin and Glycated Hemoglobin Are Influenced Differently by Endogenous Insulin Secretion in Patients With Type 2 Diabetes
por: Koga, Masafumi, et al.
Publicado: (2010)

Ultrasonography evaluation on the protective effect of combination therapy of beraprost sodium and aspirin on arteries occlusion and stiffness in patients with type 2 diabetes mellitus - a prospective, randomized study
por: Lin, Xian, et al.
Publicado: (2022)

Prediction of near‐future glycated hemoglobin levels using glycated albumin levels before and after treatment for diabetes
por: Koga, Masafumi, et al.
Publicado: (2011)

Antiatherosclerotic Potential of Clopidogrel: Antioxidant and Anti-Inflammatory Approaches
por: Hadi, Najah R., et al.
Publicado: (2013)

Combination therapy with beraprost sodium and aspirin for acute ischemic stroke: a single-center retrospective study
por: Cai, De, et al.
Publicado: (2019)

Fenofibrate improves vascular endothelial function and contractility in diabetic mice
por: Xu, Nan, et al.
Publicado: (2018)

Achievement of Lipid Targets with the Combination of Rosuvastatin and Fenofibric Acid in Patients with Type 2 Diabetes Mellitus
por: Rosenson, Robert S., et al.
Publicado: (2010)

Beraprost and Overall Survival in Cats with Chronic Kidney Disease
por: Ito, Hiroyuki, et al.
Publicado: (2023)

The Efficacy of Fenofibrate in Addition to Atorvastatin in Patients of Type II Diabetes Mellitus
por: Qasim, Muhammad, et al.
Publicado: (2022)

Prostacyclin analog beraprost sodium efficacy in primary glomerular disease or nephrosclerosis: Analysis of the Japanese subgroup in CASSIOPEIR study
por: Kurumatani, Hajimu, et al.
Publicado: (2021)

Salt overload damages the glycocalyx sodium barrier of vascular endothelium
por: Oberleithner, Hans, et al.
Publicado: (2011)

CD59 Underlines the Antiatherosclerotic Effects of C-Phycocyanin on Mice
por: Li, Bing, et al.
Publicado: (2013)

Efficacy of Beraprost Sodium Combined with Sildenafil and Its Effects on Vascular Endothelial Function and Inflammation in Patients Experiencing Left Heart Failure Complicated with Pulmonary Arterial Hypertension
por: Sun, Daoyuan, et al.
Publicado: (2021)

The Protective Effect of Beraprost Sodium on Diabetic Cardiomyopathy through the Inhibition of the p38 MAPK Signaling Pathway in High-Fat-Induced SD Rats
por: Li, Jie, et al.
Publicado: (2014)

Antiatherosclerotic Potential of Active Principle Isolated from Eugenia jambolana in Streptozotocin-Induced Diabetic Rats
por: Tanwar, Reenu Singh, et al.
Publicado: (2011)

Antiatherosclerotic and Renoprotective Effects of Ebselen in the Diabetic Apolipoprotein E/GPx1-Double Knockout Mouse
por: Chew, Phyllis, et al.
Publicado: (2010)

LOX-1, the Common Therapeutic Target in Hypercholesterolemia: A New Perspective of Antiatherosclerotic Action of Aegeline
por: Singh, Abhilasha, et al.
Publicado: (2019)

The Protective Effect of Beraprost Sodium on Diabetic Nephropathy by Inhibiting Inflammation and p38 MAPK Signaling Pathway in High-Fat Diet/Streptozotocin-Induced Diabetic Rats
por: Peng, Li, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_oj742dunc784158r4scv3mcouv